Geneos Wealth Management’s Align Technology ALGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12K Hold
71
﹤0.01% 1955
2026
Q1
$12.2K Hold
71
﹤0.01% 1933
2025
Q4
$11.1K Sell
71
-18
-20% -$2.58K ﹤0.01% 1931
2025
Q3
$11.1K Buy
89
+11
+14% +$1.72K ﹤0.01% 1929
2025
Q2
$14.8K Buy
78
+30
+63% +$5.3K ﹤0.01% 2163
2025
Q1
$7.63K Sell
48
-34
-41% -$6.67K ﹤0.01% 2369
2024
Q4
$17.1K Sell
82
-12,370
-99% -$2.76M ﹤0.01% 1807
2024
Q3
$3.17M Sell
12,452
-100
-0.8% -$23.6K 0.12% 202
2024
Q2
$3.03M Buy
12,552
+315
+3% +$87.7K 0.13% 177
2024
Q1
$4.01M Buy
12,237
+152
+1% +$44.6K 0.18% 140
2023
Q4
$3.31M Sell
12,085
-488
-4% -$116K 0.16% 153
2023
Q3
$3.84M Buy
12,573
+686
+6% +$237K 0.2% 132
2023
Q2
$4.2M Buy
11,887
+2,364
+25% +$753K 0.22% 124
2023
Q1
$3.18M Sell
9,523
-2,877
-23% -$849K 0.19% 137
2022
Q4
$2.62M Sell
12,400
-942
-7% -$189K 0.16% 151
2022
Q3
$2.76M Buy
13,342
+1,184
+10% +$305K 0.19% 128
2022
Q2
$3.01M Buy
12,158
+1,743
+17% +$536K 0.15% 157
2022
Q1
$4.54M Sell
10,415
-173
-2% -$84.2K 0.2% 124
2021
Q4
$6.96M Sell
10,588
-317
-3% -$204K 0.27% 85
2021
Q3
$7.22M Buy
10,905
+144
+1% +$97.8K 0.28% 70
2021
Q2
$6.72M Sell
10,761
-1,323
-11% -$783K 0.26% 79
2021
Q1
$7.19M Sell
12,084
-153
-1% -$84.6K 0.2% 115
2020
Q4
$6.43M Sell
12,237
-3,799
-24% -$1.71M 0.26% 82
2020
Q3
$5.1M Buy
16,036
+24
+0.1% +$7.33K 0.26% 88
2020
Q2
$4.21M Buy
16,012
+847
+6% +$191K 0.23% 101
2020
Q1
$2.68M Buy
15,165
+165
+1% +$39.5K 0.18% 127
2019
Q4
$4.16M Buy
15,000
+14,413
+2,455% +$3.59M 0.22% 122
2019
Q3
$103K Hold
587
0.01% 879
2019
Q2
$160K Sell
587
-111
-16% -$33.5K 0.01% 738
2019
Q1
$198K Buy
698
+2
+0.3% +$477 0.01% 640
2018
Q4
$144K Buy
696
+132
+23% +$33.4K 0.01% 708
2018
Q3
$220K Sell
564
-2
-0.4% -$738 0.01% 606
2018
Q2
$193K Sell
566
-18
-3% -$5.37K 0.02% 575
2018
Q1
$146K Sell
584
-24
-4% -$6.16K 0.01% 629
2017
Q4
$135K Sell
608
-38
-6% -$8.63K 0.01% 652
2017
Q3
$120K Sell
646
-65
-9% -$11.1K 0.01% 646
2017
Q2
$106K Buy
711
+247
+53% +$33.5K 0.01% 663
2017
Q1
$53K Hold
464
0.01% 858
2016
Q4
$44K Buy
464
+28
+6% +$2.6K 0.01% 881
2016
Q3
$40K Buy
436
+16
+4% +$1.45K 0.01% 896
2016
Q2
$34K Hold
420
﹤0.01% 932
2016
Q1
$30K Buy
+420
New +$27.5K ﹤0.01% 962

Other funds holding ALGN

Geneos Wealth Management's ALGN Position: Q2 2026 in Review

Geneos Wealth Management held its Align Technology (ALGN) position steady in Q2 2026 at 71 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #1955.

Geneos Wealth Management first reported a position in ALGN in Q1 2016 and has held it in 42 quarters since. The position peaked at $7.22M in Q3 2021. 671 funds tracked by Wall St. Rank hold ALGN as of Q2 2026.

  • Geneos Wealth Management held 71 shares of Align Technology worth $12K as of Q2 2026.
  • Geneos Wealth Management left its Align Technology share count unchanged in Q2 2026.
  • Align Technology made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1955 holding.
  • Geneos Wealth Management first reported a position in Align Technology in Q1 2016 and has held it in 42 quarters since.
  • Geneos Wealth Management's Align Technology position peaked at $7.22M in Q3 2021.
  • 671 funds tracked by Wall St. Rank held Align Technology as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.